LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 72.52 | 84.90 | 8890 | 9214 | 0.9648 | 0.9894 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 72.52 | 84.90 | 765 | 9214 | 0.0830 | 0.3842 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 72.52 | 84.90 | 10782 | 9214 | 1.1701 | 1.0470 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.22 | 84.90 | 953 | 9343 | 0.1020 | 0.4284 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.22 | 84.90 | 9180 | 9343 | 0.9825 | 0.9948 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.22 | 84.90 | 794 | 9343 | 0.0850 | 0.3905 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 74.22 | 84.90 | 10969 | 9343 | 1.1740 | 1.0479 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.93 | 84.90 | 999 | 8970 | 0.1114 | 0.4429 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.93 | 84.90 | 9297 | 8970 | 1.0364 | 1.0107 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.93 | 84.90 | 802 | 8970 | 0.0894 | 0.3966 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 75.93 | 84.90 | 11180 | 8970 | 1.2463 | 1.0666 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 77.64 | 84.90 | 1009 | 9245 | 0.1091 | 0.4417 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 77.64 | 84.90 | 9469 | 9245 | 1.0242 | 1.0071 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 77.64 | 84.90 | 829 | 9245 | 0.0897 | 0.4004 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 77.64 | 84.90 | 11309 | 9245 | 1.2232 | 1.0604 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 79.34 | 84.90 | 979 | 9051 | 0.1082 | 0.4376 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 79.34 | 84.90 | 9653 | 9051 | 1.0664 | 1.0192 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 79.34 | 84.90 | 789 | 9051 | 0.0872 | 0.3923 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 79.34 | 84.90 | 11603 | 9051 | 1.2819 | 1.0751 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 81.05 | 84.90 | 990 | 8863 | 0.1117 | 0.4424 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 81.05 | 84.90 | 9895 | 8863 | 1.1163 | 1.0331 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 81.05 | 84.90 | 815 | 8863 | 0.0919 | 0.4011 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 81.05 | 84.90 | 11823 | 8863 | 1.3338 | 1.0878 | MN20160318_Q02 | I21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.75 | 84.90 | 1037 | 8621 | 0.1203 | 0.4556 | MN20160318_Q02 | D17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 82.75 | 84.90 | 10135 | 8621 | 1.1755 | 1.0491 | MN20160318_Q02 | D17 |